GLP-1 receptor agonists × body weight & composition

TrialThe New England journal of medicine2021

Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined.

Julie R Lundgren et al.PubMed ↗Publisher ↗

What the trial testedrandomised · 195 people · 2021

Randomised comparison

Probably lowered body weight & composition

−4.10kg−7.80 to −0.40

As reported

difference −4.1 kg, 95% CI −7.80 to −0.40

Randomised comparison

Probably lowered body weight & composition

−5.40kg−9.00 to −1.70

As reported

difference −5.4 kg, 95% CI −9.00 to −1.70

Two numbers in the abstract

the abstract, start to end

difference in the exercise group, -4.1 kg (95% confidence interval

weight loss than exercise (difference, -5.4 kg; 95% CI, -9.0 to -1.7;

← favours treatmentfavours comparator →
could be chance
Body weight & composition
−4.1−7.80 to −0.40
Body weight & composition
−5.4−9.00 to −1.70
GLP-1 receptor agonistsDiet, exercise & lifestyleBody weight & composition

GLP-1 receptor agonists × body weight & compositionhelps?replicated

unlikelylikely
0.900.90 without it

Diet, exercise & lifestyle × body weight & compositionhelps?mixed

unlikelylikely
0.120.00 without it
← favours treatmentfavours comparator →
this papermore certainless certain
1 / 5

257 papers cite itlatest 60 shown

2021
2024
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 33951361